Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$1.07B |
| 2 |
Lam Research
LRCX
|
$763M |
| 3 |
Exxon Mobil
XOM
|
$596M |
| 4 |
Merck
MRK
|
$552M |
| 5 |
Arista Networks
ANET
|
$506M |
Top Sells
| 1 |
Broadcom
AVGO
|
$1B |
| 2 |
TSMC
TSM
|
$635M |
| 3 |
AbbVie
ABBV
|
$604M |
| 4 |
Cisco
CSCO
|
$525M |
| 5 |
Goldman Sachs
GS
|
$481M |
Sector Composition
| 1 | Technology | 27.89% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.44% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Nautilus Biotechnolgy
NAUT
$83.7M
| $179K | ﹤0.01% |
106,697
| – | – |
|
3827
Cumberland Pharmaceuticals
CPIX
$54.9M
| $178K | ﹤0.01% |
75,269
+1
| +0% | +$2 |
|
3828
Torrid Holdings
CURV
$231M
| $177K | ﹤0.01% |
33,803
-35,980
| -52% | -$188K |
|
3829
EVI Industries
EVI
$346M
| $175K | ﹤0.01% |
10,710
-5,591
| -34% | -$91.4K |
|
3830
Rumble
RUM
$2.44B
| $174K | ﹤0.01% |
13,396
+1,510
| +13% | +$19.6K |
|
3831
Expensify
EXFY
$178M
| $174K | ﹤0.01% |
+51,988
| New | +$174K |
|
|
CLPR
3832
Clipper Realty
CLPR
$69.3M
| $173K | ﹤0.01% |
37,874
-770
| -2% | -$3.53K |
|
3833
Lantronix
LTRX
$180M
| $171K | ﹤0.01% |
41,502
+18,996
| +84% | +$78.3K |
|
3834
Lineage Cell Therapeutics
LCTX
$279M
| $170K | ﹤0.01% |
337,827
+110
| +0% | +$55 |
|
3835
Gyre Therapeutics
GYRE
$699M
| $168K | ﹤0.01% |
13,896
+1,389
| +11% | +$16.8K |
|
3836
Acrivon Therapeutics
ACRV
$42.5M
| $166K | ﹤0.01% |
27,635
-1,874
| -6% | -$11.3K |
|
3837
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.72B
| $163K | ﹤0.01% |
20,002
| – | – |
|
3838
LiveWire
LVWR
$735M
| $162K | ﹤0.01% |
33,659
| – | – |
|
3839
Tilly's
TLYS
$56.7M
| $160K | ﹤0.01% |
37,678
-27,958
| -43% | -$119K |
|
3840
Acumen Pharmaceuticals
ABOS
$83.6M
| $160K | ﹤0.01% |
92,983
| – | – |
|
3841
Bioceres Crop Solutions
BIOX
$172M
| $159K | ﹤0.01% |
26,150
| – | – |
|
3842
InnovAge Holding
INNV
$494M
| $157K | ﹤0.01% |
39,992
| – | – |
|
3843
Ovid Therapeutics
OVID
$90.3M
| $155K | ﹤0.01% |
165,763
| – | – |
|
3844
BlackRock Resources & Commodities Strategy Trust
BCX
$783M
| $154K | ﹤0.01% |
18,002
-1
| -0% | -$9 |
|
3845
Hyperfine
HYPR
$91.9M
| $151K | ﹤0.01% |
171,495
| – | – |
|
3846
HilleVax
HLVX
$105M
| $151K | ﹤0.01% |
72,760
| – | – |
|
3847
ALX Oncology
ALXO
$55.2M
| $150K | ﹤0.01% |
90,003
+9,623
| +12% | +$16.1K |
|
|
AGEN
3848
Agenus
AGEN
$138M
| $150K | ﹤0.01% |
54,727
-16,375
| -23% | -$44.9K |
|
3849
Lee Enterprises
LEE
$26.1M
| $149K | ﹤0.01% |
10,112
| – | – |
|
3850
Kyverna Therapeutics
KYTX
$157M
| $149K | ﹤0.01% |
39,933
-3,333
| -8% | -$12.5K |
|